Free Trial
→ SpaceX will crumble without these 5 companies (From InvestPub) (Ad)tc pixel Free IDNA Stock Alerts

iShares Genomics Immunology and Healthcare ETF (IDNA) Chart & Stock Price History

iShares Genomics Immunology and Healthcare ETF logo
$29.77 0.00 (0.00%)
As of 06/12/2026 04:10 PM Eastern
Compare

iShares Genomics Immunology and Healthcare ETF Stock Price Performance

The iShares Genomics Immunology and Healthcare ETF (IDNA) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has increased 40.69%, with a year-to-date return of 13.67%. In the past month, the fund has increased 3.33%, reflecting recent market activity.

As of the latest close, iShares Genomics Immunology and Healthcare ETF traded at $29.77 with a market cap of $162.25 million and volume of 17,276 shares. Five years ago, the fund traded at $48.56, representing a 38.69% decrease over that period. At the time, it had a market cap of $307.40 million and a volume of 27,556 shares.

Receive IDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+3.91%
1 Month
Performance
+3.33%
3 Month
Performance
+3.44%
Year-To-Date
Performance
+13.67%
1 Year
Performance
+40.69%
5 Year
Performance
-38.69%

IDNA Stock Chart for Monday, June, 15, 2026

IDNA Chart by TradingView

iShares Genomics Immunology and Healthcare ETF Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
06/12/2026$29.52$29.77
+0.85%		$30.01$29.6217,276 shs$162.25 million
06/11/2026$28.65$29.52
+3.04%		$29.67$28.7923,115 shs$160.88 million
06/10/2026$29.20$28.65
-1.88%		$29.33$28.5715,928 shs$156.14 million
06/09/2026$29.06$29.20
+0.48%		$29.49$28.705,390 shs$159.14 million
06/08/2026$29.14$29.06
-0.27%		$29.58$28.959,813 shs$158.38 million
06/05/2026$29.96$29.14
-2.74%		$29.91$29.1039,694 shs$158.81 million
06/04/2026$28.89$29.96
+3.70%		$30.22$29.2762,115 shs$163.28 million
06/03/2026$28.68$28.89
+0.73%		$28.97$28.5318,322 shs$157.45 million
06/02/2026$29.32$28.68
-2.18%		$29.00$28.6069,543 shs$156.31 million
06/01/2026$29.88$29.32
-1.87%		$29.64$29.0531,054 shs$159.79 million
05/29/2026$30.08$29.88
-0.66%		$30.11$29.8122,264 shs$162.85 million
05/28/2026$29.81$30.08
+0.91%		$30.10$29.5162,400 shs$163.94 million
05/27/2026$29.75$29.81
+0.20%		$30.22$29.7017,869 shs$162.46 million
05/26/2026$29.45$29.75
+1.02%		$29.80$29.4933,698 shs$162.14 million
05/25/2026$29.45$29.45$29.79$29.4218,751 shs$160.50 million
05/22/2026$29.48$29.45
-0.10%		$29.79$29.4218,751 shs$160.50 million
05/21/2026$29.20$29.48
+0.96%		$29.55$28.8110,775 shs$160.67 million
05/20/2026$28.37$29.20
+2.93%		$29.26$28.6522,691 shs$159.14 million
05/19/2026$28.52$28.37
-0.53%		$28.54$28.2016,521 shs$154.62 million
05/18/2026$28.81$28.52
-1.01%		$28.72$28.3128,691 shs$155.43 million
05/15/2026$29.54$28.81
-2.47%		$29.40$28.7626,040 shs$157.01 million
05/14/2026$29.80$29.54
-0.87%		$29.92$29.4723,959 shs$160.99 million
Related Companies

This page (NYSEARCA:IDNA) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel